← Open Payments lookup

RACHEL SOUTHARD: Open Payments

NPI 1669809604 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,116 in 48 payments from 19 companies in 2025. Trend: 2023 $451 · 2024 $860 · 2025 $1,116

Food & beverage: $1,116
CompanyPaymentsAmount
ABBVIE INC.7$146
Novo Nordisk Inc5$125
AstraZeneca Pharmaceuticals LP5$121
GlaxoSmithKline, LLC.4$105
Lilly USA, LLC4$95
Takeda Pharmaceuticals U.S.A., Inc.4$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$62
Actelion Pharmaceuticals US, Inc.2$56
Exact Sciences Corporation2$46
Boehringer Ingelheim Pharmaceuticals, Inc.2$41

Products named: TRINTELLIX, BREZTRI, UBRELVY, MOUNJARO, XIFAXAN, TRELEGY ELLIPTA, OPSUMIT, Wegovy.

Industry payments across MA — which companies pay providers there.